Last €8.99 EUR
Change Today -0.11 / -1.21%
Volume 7.7K
SSI On Other Exchanges
Symbol
Exchange
EN Paris
Berlin
As of 11:35 AM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

supersonic imagine sa (SSI) Snapshot

Open
€9.18
Previous Close
€9.10
Day High
€9.20
Day Low
€8.90
52 Week High
05/29/14 - €11.58
52 Week Low
08/8/14 - €7.03
Market Cap
144.4M
Average Volume 10 Days
5.8K
EPS TTM
--
Shares Outstanding
16.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SUPERSONIC IMAGINE SA (SSI)

Related News

No related news articles were found.

supersonic imagine sa (SSI) Related Businessweek News

No Related Businessweek News Found

supersonic imagine sa (SSI) Details

SuperSonic Imagine SA operates as a medical imaging company. The company develops the Aixplorer, an ultrasound system used in various applications, such as general imaging, women’s healthcare, vascular, hepatology/gastroenterology, and research. The company sells its products through a direct sales force and a distribution network in approximately 50 countries worldwide. SuperSonic Imagine SA was founded in 2005 and is headquartered in Aix-en-Provence, France.

126 Employees
Last Reported Date: 03/27/14
Founded in 2005

supersonic imagine sa (SSI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

supersonic imagine sa (SSI) Key Developments

Supersonic Imagine Launches multicentric Clinical Trial

SuperSonic Imagine announced the launch of a multicentric clinical trial. The aim of the trial is to determine how ShearWave(TM) Elastography can contribute to the diagnosis of breast lesions in a population of Asian patients. The initiative is part of the company's clinical strategy and aims at validating the clinical benefits of its technology. A previous study in 2011 involving 1,800 patients demonstrated that ShearWave(TM) Elastography, combined with conventional ultrasound criteria, provided better diagnosis of mammary lesions by significantly improving the specificity of the examination. Since then, the elastography criterion has been incorporated into the BI-RADS(R) classification by the American College of Radiology, and other academic societies have published recommendations of practice that unanimously acknowledge the results of the initial trial. The trial currently underway in China will recruit approximately 2,000 patients. In addition to confirming the benefits of ShearWave(TM) Elastography on a broad population, the primary objective is to determine the clinical benefits of this technology on a specific group which differs from the Caucasian population, given that Asian women tend to have denser breast tissue. The direction of the trial promoted by SuperSonic Imagine, has been entrusted to Professor Chang (Shanghai) and Professor Li (Guangzhou). Professors Chang and Li will be responsible for controlling the data collected from the 20 locations, which include the finest hospitals in Shanghai, Guangzhou, Beijing, Harbin, Xi'an, Chengdu, and Taiyuan.

SuperSonic Imagine SA(ENXTPA:SSI) added to CAC All-Tradable Index

SuperSonic Imagine SA will be added to the CAC All-Tradable Index.

SuperSonic Imagine SA(ENXTPA:SSI) added to CAC Small Index

SuperSonic Imagine SA will be added to the CAC Small Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SSI:FP €8.99 EUR -0.11

SSI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SSI.
View Industry Companies
 

Industry Analysis

SSI

Industry Average

Valuation SSI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.1x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUPERSONIC IMAGINE SA, please visit www.supersonicimagine.fr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.